EFFICACY OF DUPILUMAB IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND WITH HIGH SLEEP DISTURBANCE: A POST HOC ANALYSIS FROM LIBERTY ASTHMA QUEST

被引：0
|
作者：
Maspero, J. [1 ]
Shafazand, S. [2 ]
Cole, J. [3 ]
Pavord, I. D. [4 ]
Busse, W. W. [5 ]
Msihid, J. [6 ]
Gall, R. [7 ]
Soler, X. [7 ]
Siddiqui, S. [7 ]
Khan, A. H. [6 ]
Gomez, L. D. P. [8 ]
Jacob-Nara, J. A. [9 ]
机构：
[1] Fdn CIDEA, Buenos Aires, DF, Argentina
[2] Miller Sch Med, Miami, FL USA
[3] OK Clin Res, Edmond, OK USA
[4] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[5] Univ Wisconsin, UW Allergy Pulm & Crit Care Med, Madison, WI USA
[6] Sanofi, Chilly Mazarin, France
[7] Regeneron, Tarrytown, NY USA
[8] Sanofi, Reading, Berks, England
[9] Sanofi, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR53
引用
收藏
页码：S550 / S550
页数：1
相关论文
共 50 条
  • [41] Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype
    Papadopoulos, Nikolaos
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [42] DUPILUMAB EFFICACY IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND SEROLOGIC EVIDENCE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    Corren, J.
    Sher, L.
    Zhu, X.
    Rice, M.
    Deniz, Y.
    Rowe, P.
    Staudinger, H.
    Ruddy, M.
    Patel, N.
    Graham, N.
    Teper, A.
    Amin, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S15 - S15
  • [43] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma and Serologic Evidence of Allergic Bronchopulmonary Aspergillosis
    Corren, J.
    Sher, L.
    Zhu, X.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Staudinger, H. W.
    Ruddy, M.
    Patel, N.
    Graham, N. M. H.
    Teper, A.
    Amin, N.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [44] DUPILUMAB IMPROVES ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA, REGARDLESS OF EXACERBATION HISTORY
    Corren, J.
    Castro, M.
    Maspero, J.
    Cosio, B.
    Kuna, P.
    Chen, Z.
    Staudinger, H.
    Chao, J.
    Nikhil, A.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    Khan, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S42 - S43
  • [45] Baseline FeNO as a Prognostic Biomarker for Subsequent Severe Asthma Exacerbations in Patients With Uncontrolled, Moderate-to-Severe Asthma Receiving Placebo in the LIBERTY ASTHMA QUEST Study
    Busse, William
    Pavord, Ian
    Wenzel, Sally
    Bateman, Eric
    Casale, Thomas
    FitzGerald, J.
    Rice, Megan
    Deniz, Yamo
    Patel, Naimish
    Harel, Sivan
    Rowe, Paul
    Graham, Neil
    O'Riordan, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB21 - AB21
  • [46] Dupilumab Reduced Severe Exacerbations and Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Eosinophilic Phenotype Across Baseline IgE Levels: LIBERTY ASTHMA QUEST Study
    Carr, W. W.
    Corren, J.
    Casale, T. B.
    Daizadeh, N.
    Khan, A. H.
    Kamat, S.
    Deniz, Y.
    Rowe, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [47] FeNO as a Potential Prognostic and Predictive Marker of Lung Function Decline in Patients with Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA QUEST
    Pavord, I. D.
    Brusselle, G.
    Jackson, D. J.
    Brightling, C. E.
    Papi, A.
    Maspero, J. F.
    Rabe, K. F.
    Korn, S.
    Zhang, M.
    Djandji, M.
    Hardin, M.
    Gomez, L. De Prado
    Jacob-Nara, J. A.
    Rowe, P. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [48] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA PATIENTS REGARDLESS OF PRIOR EXACERBATION HISTORY IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Pavord, I.
    Ford, L. B.
    Corren, J.
    Kuna, P.
    Dong, Q.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Rout, R.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    THORAX, 2018, 73 : A121 - A122
  • [49] A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
    Maspero, J. F.
    Kuna, P.
    Ford, L. B.
    Valero Santiago, A.
    Daizadeh, N.
    Rowe, P.
    Deniz, Y.
    Kamat, S.
    Khan, A. H.
    Pandit-Abid, N.
    Ortiz, B.
    ALLERGY, 2020, 75 : 16 - 16
  • [50] Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial
    Rhee, Chin Kook
    Park, Jung-Won
    Park, Heung-Woo
    Noh, Hayeon
    Msihid, Jerome
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2024, 16 (04) : 372 - 386
12345